GLENMARK 1840 CE CALL indicators chart analysis Glenmark Pharmaceuticals Limited options price chart strike 1840 CALL
Options premium and indicators chart analysis for GLENMARK 1840 CE CALL indicators chart analysis Glenmark Pharmaceuticals Limited options price chart strike 1840 CALL
Glenmark Pharmaceuticals Limited GLENMARK trades in NSE under Pharmaceuticals NSE
Premium of GLENMARK 1840 CALL CE Sep 26 2024
Premium of CALL (CE) of strike 1840 is at: 2.35 on 23 Sep 2024
CALL opened at 5.45 and traded inside a Low-High range of 2.15-8.85
as on 23 Mon Sep 2024
The underlying equity is trading at 1712.45 which means that CALL of strike 1840 is OTM CALL option (out of the money)
Lot size of GLENMARK Glenmark Pharmaceuticals Limited is 1150
Total Open Interest for CALL (CE) of strike 1840 is 214,600
Price action analysis of 1840 CALL based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of 1840 CALL based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Indicators are giving a buy signal for buyers, but a exit signal is generated by indicators for sellers of 1840 CALL of Glenmark Pharmaceuticals Limited
Click here to view most profitable CE and PE for Glenmark Pharmaceuticals Limited, both for buyers and sellers | GLENMARK Most Active Call Put Options
Date | Underlying price | CE price | CE open | CE high | CE low | CE volume | CE OI | OI Change |
23 Mon Sep | 1712.45 | 2.35 | 5.45 | 8.85 | 2.15 | 135 | 246,790,000 | 202% |
20 Fri Sep | 1636.75 | 1.00 | 1.90 | 2.00 | 0.85 | -47 | 81,707,500 | -4.9% |
19 Thu Sep | 1649.80 | 1.90 | 2.00 | 2.15 | 1.50 | 2 | 85,876,250 | -1% |
18 Wed Sep | 1646.05 | 1.85 | 2.80 | 3.75 | 1.70 | -49 | 86,710,000 | -15.4% |
17 Tue Sep | 1713.00 | 3.65 | 5.95 | 5.95 | 3.60 | -38 | 102,551,250 | -14.6% |
16 Mon Sep | 1741.45 | 5.95 | 8.20 | 8.40 | 5.50 | -30 | 120,060,000 | 11.6% |